Mechanistic Toxicity

Evotec and wholly owned subsidiary Cyprotex have combined expertise in toxicology which spans from early discovery through to the clinic so we have a full picture of the entire drug discovery and development continuum and can support you at every stage of your project. The scientific expertise and capabilities can be accessed as fee-for-services or as part of partially or fully integrated programs.

Mechanistic Toxicity Services

The first step in our understanding of drug- or chemical-induced toxicity is identifying potential mechanisms by evaluating specific adverse outcome perturbations, whether these are molecular, organelle or cellular effects and relating these to organ-specific toxicity.

Cyprotex offers a number of different assays to elucidate specific mechanisms of toxicity.

These include:

  • Cell Stress Panel - assesses 36 biomarkers that represent cellular stress signalling pathways, organelle health and cellular cytotoxicity.

  • Phospholipidosis - lysosomal storage disorder characterised by excessive accumulation of intracellular phospholipids in tissues.

  • Steatosis - hepatic lipid processing disorder, leading to accumulation of triglycerides within the liver cells.

  • Haemolysis - evaluates hemoglobin release in the plasma (as an indicator of red blood cell lysis).

  • Functional Mitochondrial Toxicity  – uses the Seahorse XFe96 extracellular flux analyser to determine oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) to assess cellular bioenergetics and potential mechanisms of mitochondrial toxicity.

  • Mitochondrial Respiratory Complex Assay (using Permeabilised Cells)  – uses the Seahorse XFe96 extracellular flux analyser to decipher which complex is involved in the mitochondrial toxicity.
  • Reactive Metabolite Assessment – uses glutathione (GSH), potassium cyanide (KCN) or cysteine (Cys) trapping studies with human liver microsomes and LC-MS/MS detection.

  • Cell Viability - general cell viability assessment using single endpoints such as LDH (lactate dehydrogenase), neutral red or MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide).

  • Transcriptomics – using high throughput RNA-seq combined with a sophisticated bioinformatics platform to determine the drug or chemical-induced effects on the transcriptome.

  • Custom Toxicology – flexible service where we can investigate different cell lines, endpoints and time points to address particular customer issues.

Cyprotex eStore

Order our services online.

Visit the Cyprotex eStore

Contact Our Experts

Caroline Bauch

Caroline Bauch

Principal Scientist

Logo Cyprotex white
Cyprotex enables and enhances the prediction of human exposure, clinical efficacy and toxicological outcome of a drug or chemical. By combining quality data from robust in vitro methods with contemporary in silico technology, we add value, context and relevance to the ADME-Tox data supplied to our partners in the pharmaceutical or chemical industries.